UTAH MEDICAL PRODUCTS INC
For the period ended Dec 31, 2024. Filed Mar 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Market Information
UTMD's common stock trades on the NASDAQ Global Market (stock symbol: UTMD). The following table sets forth the high and low sales price information as reported by NASDAQ for the periods indicated:
| 2024 | 2023 | |||
|---|---|---|---|---|
| High | Low | High | Low | |
| 1st Quarter | $85.76 | $68.00 | $101.41 | $80.75 |
| 2nd Quarter | 71.55 | 65.91 | 100.59 | 87.54 |
| 3rd Quarter | 77.33 | 65.60 | 99.46 | 83.63 |
| 4th Quarter | 68.99 | 60.39 | 87.99 | 75.00 |
Stockholders.
The number of beneficial stockholders of UTMD’s common stock as of March 3, 2025 was at least 2,000.
Dividends.
The following sets forth cash dividends paid during the past two years:
| Record Date | Payable Date | Per Share Amount |
|---|---|---|
| March 17, 2023 | April 4, 2023 | 0.295 |
| June 16, 2023 | July 6, 2023 | 0.295 |
| September 15, 2023 | October 3, 2023 | 0.295 |
| December 15, 2023 | January 3, 2024 | 0.300 |
| March 15, 2024 | April 3, 2024 | 0.300 |
| June 14, 2024 | July 5, 2024 | 0.300 |
| September 20, 2024 | October 4, 2024 | 0.300 |
| December 16, 2024 | January 3, 2025 | 0.305 |
| 2023 total cash dividends paid per share | $ 1.1800 | |
| 2024 total cash dividends paid per share | $ 1.2000 |
Issuer Purchases of Equity Securities.
UTMD did not purchase any of its own securities in 2023. In 2024, UTMD purchased 301,961 shares of its common stock for $19,968 including commissions and fees (an average price of $66.13/ share).
| 2024 Calendar Quarter | Shares Repurchased | Average Cost Per Share | TotalCost [K] |
|---|---|---|---|
| 1Q 2024 | 43,108 | $ 69.368 | $ 2,990 |
| 2Q 2024 | 95,107 | 67.326 | 6,403 |
| 3Q 2024 | 58,377 | 66.220 | 3,866 |
| 4Q 2024 | 105,369 | 63.667 | 6,709 |
| Year Total | 301,961 | $ 66.127 | $ 19,968 |
As a subsequent 2025 event, through March 4, 2025 UTMD purchased 36,909 additional shares of its common stock for $2,217 including commissions and fees (an average price of $60.08/ share).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.